NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
2.11
-0.05 (-2.31%)
At close: Sep 25, 2025, 3:59 PM
2.16
2.37%
After-hours: Sep 25, 2025, 05:25 PM EDT
-2.31% (1D)
| Bid | 2.07 |
| Market Cap | 12.28M |
| Revenue (ttm) | 4.75M |
| Net Income (ttm) | 3.32M |
| EPS (ttm) | 2.3 |
| PE Ratio (ttm) | 0.92 |
| Forward PE | -5.63 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.25 |
| Volume | 188,662 |
| Avg. Volume (20D) | 6,969,579 |
| Open | 2.18 |
| Previous Close | 2.16 |
| Day's Range | 2.06 - 2.19 |
| 52-Week Range | 0.46 - 4.44 |
| Beta | 0.63 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for NBY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
+72.42%
NovaBay Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
1 month ago
-0.83%
NovaBay Pharmaceuticals shares are trading higher after the company announced a one-time special cash dividend of $0.80 per share.
